<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To identify early risk factors for pregnancy loss in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> pregnancies </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We conducted a cohort study of <z:hpo ids='HP_0000001'>all</z:hpo> pregnancies seen in the first trimester in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> patients followed from 1987 to 2002 at the Hopkins <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> Center </plain></SENT>
<SENT sid="2" pm="."><plain>At each visit, vital signs, a complete blood count, a urinalysis, and a 24-hour urine collection for total protein, if the dipstick revealed <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, were obtained </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000093'>Proteinuria</z:hpo> was defined as protein greater than 500 mg in a 24-hour urine collection </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">Secondary antiphospholipid syndrome</z:e> was diagnosed by using the Sapporo criteria </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> was defined as platelets under 150,000 </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> was defined as blood pressure over 140/90 mm Hg during the first trimester </plain></SENT>
<SENT sid="7" pm="."><plain>Pregnancies electively terminated were excluded from this study </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: One hundred sixty-six pregnancies in 125 women were followed in the Hopkins <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> Cohort from the first trimester onward </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty-seven pregnancies (16%) ended with a loss </plain></SENT>
<SENT sid="10" pm="."><plain>Pregnancy loss was increased 2.6 times in women with first-trimester <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (P = .04) </plain></SENT>
<SENT sid="11" pm="."><plain>A diagnosis of <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> led to a 3.1-fold increase in pregnancy loss, predominantly after 20 weeks of gestation (P = .004) </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> in the first trimester led to an increase in pregnancy loss by 3.3 fold (P &lt; or = .001) </plain></SENT>
<SENT sid="13" pm="."><plain>First-trimester <z:hpo ids='HP_0000822'>hypertension</z:hpo> led to a 2.4-fold increase in pregnancy loss (P = .027) </plain></SENT>
<SENT sid="14" pm="."><plain>Each risk factor was independent in raising pregnancy loss risk </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSION: The acronym PATH can help remind clinicians to monitor for <z:hpo ids='HP_0000093'>Proteinuria</z:hpo>, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e>, <z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo>, and <z:hpo ids='HP_0000822'>Hypertension</z:hpo> early in pregnancy </plain></SENT>
<SENT sid="16" pm="."><plain>Close observation, with frequent laboratory analysis and appropriate therapy, is important to pregnancy success in women with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="17" pm="."><plain>LEVEL OF EVIDENCE: II-2 </plain></SENT>
</text></document>